AI assistant
Sending…
Genprex, Inc. — Director's Dealing 2021
Sep 28, 2021
35333_dirs_2021-09-28_3655cb9f-9550-4d3f-8629-8df7bf666abb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Genprex, Inc. (GNPX)
CIK: 0001595248
Period of Report: 2021-09-27
Reporting Person: Berger Mark Stanley (Chief Medical Officer)
More from Genprex, Inc.
Regulatory Filings
2026
Jun 5
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 14
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 21
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27
Regulatory Filings
2026
Feb 23
Major Shareholding Notification
2026
Feb 11